Literature DB >> 20400524

Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes.

Charalampos Tzoulis1, Gesche Neckelmann, Sverre J Mørk, Bernt E Engelsen, Carlo Viscomi, Gunnar Moen, Lars Ersland, Massimo Zeviani, Laurence A Bindoff.   

Abstract

Mutations in the catalytic subunit of the mitochondrial DNA-polymerase gamma cause a wide spectrum of clinical disease ranging from infantile hepato-encephalopathy to juvenile/adult-onset spinocerebellar ataxia and late onset progressive external ophthalmoplegia. Several of these syndromes are associated with an encephalopathy that characteristically shows episodes of rapid neurological deterioration and the development of acute cerebral lesions. The purpose of this study was to investigate the nature, distribution and natural evolution of central nervous system lesions in polymerase gamma associated encephalopathy focusing particularly on lesions identified by magnetic resonance imaging. We compared radiological, electrophysiological and pathological findings where available to study potential mechanisms underlying the episodes of exacerbation and acute cerebral lesions. We studied a total of 112 magnetic resonance tomographies and 11 computed tomographies in 32 patients with polymerase gamma-encephalopathy, including multiple serial examinations performed during both the chronic and acute phases of the disease and, in several cases, magnetic resonance spectroscopy and serial diffusion weighted studies. Data from imaging, electroencephalography and post-mortem examination were compared in order to study the underlying disease process. Our findings show that magnetic resonance imaging in polymerase gamma-related encephalopathies has high sensitivity and can identify patterns that are specific for individual syndromes. One form of chronic polymerase gamma-encephalopathy, that is associated with the c.1399G > A and c.2243G > C mutations, is characterized by progressive cerebral and cerebellar atrophy and focal lesions of the thalamus, deep cerebellar structures and medulla oblongata. Acute encephalopathies, both infantile and later onset, show similar pictures with cortical stroke-like lesions occurring during episodes of exacerbation. These lesions can occur both with and without electroencephalographic evidence of concurrent epileptic activity, and have diffusion, spectroscopic and histological profiles strongly suggestive of neuronal energy failure. We suggest therefore that both infantile and later onset polymerase gamma related encephalopathies are part of a continuum.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400524     DOI: 10.1093/brain/awq067

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

1.  POLG mutation presenting with late-onset jerky torticollis.

Authors:  Anil M Tuladhar; F J Anton Meijer; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2012-12-05       Impact factor: 4.849

2.  Mitochondrial POLG related disorder presenting prenatally with fetal cerebellar growth arrest.

Authors:  Michal Inbar-Feigenberg; Susan Blaser; Cynthia Hawkins; Patrick Shannon; Stacy Hewson; David Chitayat
Journal:  Metab Brain Dis       Date:  2018-03-25       Impact factor: 3.584

Review 3.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

Review 4.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  Characterizing POLG ataxia: clinics, electrophysiology and imaging.

Authors:  Matthis Synofzik; Karin Srulijes; Jana Godau; Daniela Berg; Ludger Schöls
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

6.  Disseminated stroke-like episodes lesions in MELAS are partially reversible with lactate disappearance.

Authors:  Yuya Kobayashi; Seishu Karasawa; Nobuhiko Ohashi; Kanji Yamamoto
Journal:  Acta Neurol Belg       Date:  2022-06-08       Impact factor: 2.396

7.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

8.  The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations.

Authors:  Omar Hikmat; Charalampos Tzoulis; Wui K Chong; Latifa Chentouf; Claus Klingenberg; Carl Fratter; Lucinda J Carr; Prab Prabhakar; Nandhini Kumaraguru; Paul Gissen; J Helen Cross; Thomas S Jacques; Jan-Willem Taanman; Laurence A Bindoff; Shamima Rahman
Journal:  Genet Med       Date:  2017-04-27       Impact factor: 8.822

9.  Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.

Authors:  Nichola Zoe Lax; Philippa Denis Hepplewhite; Amy Katherine Reeve; Victoria Nesbitt; Robert McFarland; Evelyn Jaros; Robert William Taylor; Douglass Matthew Turnbull
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

10.  Novel Autosomal Recessive c10orf2 Mutations Causing Infantile-Onset Spinocerebellar Ataxia.

Authors:  Jessica N Hartley; Frances A Booth; Marc R Del Bigio; Aizeddin A Mhanni
Journal:  Case Rep Pediatr       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.